Denali Therapeutics, Inc. (DNLI)
19.84
-0.29
(-1.44%)
USD |
NASDAQ |
Sep 18, 09:57
Denali Therapeutics 30-Day Average Daily Volume : 1.321M for Sept. 17, 2026
30-Day Average Daily Volume Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| September 17, 2026 | 1.321M |
| September 16, 2026 | 1.311M |
| September 15, 2026 | 1.282M |
| September 14, 2026 | 1.270M |
| September 11, 2026 | 1.275M |
| September 10, 2026 | 1.271M |
| September 09, 2026 | 1.286M |
| September 08, 2026 | 1.286M |
| September 04, 2026 | 1.289M |
| September 03, 2026 | 1.301M |
| September 02, 2026 | 1.281M |
| September 01, 2026 | 1.266M |
| August 31, 2026 | 1.256M |
| August 28, 2026 | 1.264M |
| August 27, 2026 | 1.291M |
| August 26, 2026 | 1.349M |
| August 25, 2026 | 1.386M |
| August 24, 2026 | 1.541M |
| August 21, 2026 | 1.560M |
| August 20, 2026 | 1.584M |
| August 19, 2026 | 1.604M |
| August 18, 2026 | 1.609M |
| August 17, 2026 | 1.620M |
| August 14, 2026 | 1.631M |
| August 13, 2026 | 1.653M |
| Date | Value |
|---|---|
| August 12, 2026 | 1.648M |
| August 11, 2026 | 1.666M |
| August 10, 2026 | 1.700M |
| August 07, 2026 | 1.865M |
| August 06, 2026 | 1.847M |
| August 05, 2026 | 1.796M |
| August 04, 2026 | 1.815M |
| August 03, 2026 | 1.836M |
| July 31, 2026 | 1.870M |
| July 30, 2026 | 1.916M |
| July 29, 2026 | 1.927M |
| July 28, 2026 | 1.930M |
| July 27, 2026 | 1.933M |
| July 24, 2026 | 1.940M |
| July 23, 2026 | 1.984M |
| July 22, 2026 | 2.011M |
| July 21, 2026 | 2.030M |
| July 20, 2026 | 2.065M |
| July 17, 2026 | 2.086M |
| July 16, 2026 | 2.066M |
| July 15, 2026 | 2.044M |
| July 14, 2026 | 2.036M |
| July 13, 2026 | 1.901M |
| July 10, 2026 | 1.883M |
| July 09, 2026 | 1.890M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 1.516M |
| Oncolytics Biotech, Inc. | 845959.6 |
| Sangamo Therapeutics, Inc. | 3.233M |
| Sarepta Therapeutics, Inc. | 3.013M |
| Anixa Biosciences, Inc. | 304372.0 |